FAST ASSIGNMENT OF ADEQUATE NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS BASED ON THE IDENTIFICATION OF CONSTITUTIONAL BRCA1 MUTATIONS

摘要

Subject of invention allow to synthesize DNA and identification of germline BRCAl genetic abnormalities which are correlated with a significantly decreased clinical response to neoadjuvant chemotherapy based on taxane-derived cytostatics in breast cancer patients.